DAWN
Day One Biopharmaceuticals, Inc. Common StockRecent alerts on DAWN
All signals →
News
Day One (DAWN) In-Licenses MabCare Cancer Candidate, Stock Up
14d ago
News
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio
88d ago
News
Day One Biopharma to be acquired by Servier for $2.5B
88d ago
Scanner
Unusual buy pressure (4.4x avg, 61% up-volume, +27.7% / +2.81 intraday, above VWAP)
89d ago
SEC filing
DAWN Reports $441M Cash, OJEMDA Approval, Mersana Deal, 2026 Growth Plans
92d ago
Insider trade
Sale by Adam Dubow
103d ago
Insider trade
Sale by Michael Vasconcelles
103d ago
Insider trade
Sale by Charles N York II
103d ago
Short volume
Short volume 75% of volume (4.9σ)
107d ago
News
Day One projects 2026 OJEMDA U.S. net product revenue between $225M - $250M
141d ago
News
Day One Completes Acquisition of Mersana Therapeutics
147d ago
News
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alexander & Baldwin, Inc. (NYSE - ALEX), United Security Bancshares (Nasdaq - UBFO), Udemy, Inc. (Nasdaq - UDMY), Mersana Therapeutics, Inc. (Nasdaq - MRSN)
153d ago
News
Day One Biopharma Expands Oncology Pipeline With $285 Million Mersana Buyout
155d ago
Get push alerts for DAWN
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS